Categories
Latest Industry Intelligence
Lu Rahman looks at the role of the biotech sector in the development of new [...]
Lu Rahman looks at the rise of proteomics, its growing role in the quest for new [...]
Dr Lotfi Chouchane and Dr. Javaid Sheikh, Weill Cornell Medicine-Qatar, outline the challenges and opportunities ahead for drug discovery Precision medicine is an emerging model for the next generation of [...]
Microbiome-based evidence is set to drive understanding of how drugs interact with human ‘host’ environments, helping devise more targeted treatments and create business opportunities, reports Anthony Finbow, CEO of Eagle [...]
The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses [...]
Several pharmacological treatments for non-alcoholic steatohepatitis (NASH) are expected to be launched in the seven major markets (7MM*) over the next 10 years. It is anticipated that these products can [...]
Lu Rahman looks at the rise of proteomics, its growing role in the quest for new treatments and some of the work being carried out in this field. Due to the [...]
Lu Rahman looks at the role of the biotech sector in the development of new therapeutics and why this industry is a vital element in drug discovery For reasons we [...]
DNA synthesis company Twist Bioscience has developed a revolutionary, silicon-based approach to building synthetic DNA. By miniaturising chemistry, and maximising synthesis throughout, it has ramped up the availability and accessibility [...]
Deep Pharma Intelligence announces the release of a new, open-access 130-page analytical report and interactive analytics Dashboard: AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview 2020. This delivers [...]
Advancements in technology, and in particular, developments in artificial intelligence (AI) are revolutionising the way that we live our lives. Up to now, we have used it to help us [...]
The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized [...]
Collaborative Research Leads To New Understanding Of Biomarkers By Dr Max Ryadnov and Professor Jason Crain A new collaborative research paper sheds light on the way antibodies distinguish between different [...]
Guidelines & Recommendations For Analyzing and Interpreting GPCR Second Messenger Data Sponsored by CisBio The question of choosing which methods to use for analyte quantification (signal vs concentration determination, parameters, [...]
Menu ≡ ╳ 
